The state health department in Karnataka has begun a door-to-door campaign to distribute anti-filarial drugs, targeting 18.6 ...
Q4 2024 Earnings Conference Call February 14, 2025 3:00 AM ETCompany ParticipantsMasamichi Terabatake - Group President ...
IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and biologics, today announced ...
13h
AZoLifeSciences on MSNCRISPR-Cas9 Off-Target Effects: Challenges and SolutionsThe CRISPR-Cas9 system offers groundbreaking genome editing capabilities, yet off-target cleavage raises concerns about ...
Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, announces a change in its Board of Directors with the departure ...
No-code platforms can offer the ability to surface business insights, but their true value lies in enabling action.
Blizzard is finally letting fun be louder than balance in Overwatch 2.
Oxurion NV announces changes in Board of Directors with the departure of two members and the integration of Nelly Souleymane, strengthening governance and strategic expertise in communication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results